Search

Editors

Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in Novartis (21)

Monday
Aug272018

Job: Executive Director, E&C Head of Policy & Strategic Excellence

Job Title: Executive Director, E&C Head of Policy & Strategic Excellence

Employer: Novartis

Location: East Hanover, New Jersey USA

Click to read more ...

Tuesday
Aug212018

Job: Executive Director, E&C Head of Policy & Strategic Excellence

Job Title: Executive Director, E&C Head of Policy & Strategic Excellence

Employer: Novartis

Location: East Hanover, New Jersey USA

Click to read more ...

Tuesday
Aug142018

Siemens CCO takes top compliance post at Novartis

Dr. Klaus MoosmayerBig pharma Novartis said Tuesday that it named Dr. Klaus Moosmayer as its new Chief Ethics, Risk and Compliance Officer.

Click to read more ...

Monday
Apr092018

Job: Director, Ethics & Compliance Franchise Advisor: Ophtha/Respiratory

Job Title: Director, Ethics & Compliance Franchise Advisor: Ophtha/Respiratory

Employer: Novartis

Location: East Hanover, New Jersey USA

Click to read more ...

Monday
Jan222018

Job: Director, Ethics & Compliance Functional Advisor, Patient Access/Health Policy

Job Title: Director, Ethics & Compliance Functional Advisor, Patient Access/Health Policy

Employer: Novartis

Location: East Hanover, New Jersey USA

Click to read more ...

Friday
Apr282017

South Korea fines Novartis $48 million for doctor kickbacks

South Korea Thursday fined Swiss pharma Novartis $48.3 million for paying doctors kickbacks to prescribe the company's drugs.

Click to read more ...

Thursday
Apr202017

Elizabeth David-Barrett: Pharmas and the repeated failure of anti-bribery compliance

Pharmaceuticals companies continue to fall foul of the FCPA and other anti-bribery laws, with a number of 2016 cases suggesting a vulnerability around marketing practices especially in the Asia-Pacific region. Why does a sector that is way ahead of the compliance game in so many ways keep getting caught out by anti-bribery laws?

Click to read more ...

Wednesday
Jan042017

Compliance Alert: Speaker fees are often toxic

Last month Forest Labs paid $38 million to settle allegations it paid doctors speaker fees for sometimes phony events so they would prescribe its drugs. It was the latest in a string of "speaker fee" cases.

Click to read more ...

Thursday
Aug112016

Compliance Alert: Gift-giving, rebates and kickbacks in South Korea

It is customary to send gifts and make cash donations in the regular course of business in South Korea. Exchanging gifts is a deeply rooted custom in Korean society, and this practice has historically been the source of various compliance issues for multinational companies operating in South Korea.

Click to read more ...

Monday
Apr252016

Novartis: New criminal probe in Korea for using medical journals to pay doctors

Novartis AG said in a securities filing last week that Korean prosecutors launched a criminal investigation into allegations that "Novartis Korea utilized medical journals to provide inappropriate economic benefits to healthcare professionals."

Click to read more ...

Wednesday
Mar232016

Novartis pays $25 million to SEC to resolve China FCPA offenses

Pharma giant Novartis AG agreed Wednesday to pay $25 million to settle charges that it violated the Foreign Corrupt Practices Act when two China-based subsidiaries bribed doctors and others to prescribe its drugs. 

Click to read more ...

Thursday
Oct162014

Novartis employee pleads guilty in Poland bribe case

An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.

Click to read more ...